MK-677 Capsules Price Comparison — Prices & Recorded COA Details

Compare MK-677 capsule prices, capsule count, mg per capsule, cost per capsule, and recorded COA metadata. Inspect actual batch reports independently.

Compare MK-677 Capsules purchase prices, nominal quantities, discount codes and recorded COA fields. Availability flags, purity values and dates are metadata, not independent verification; inspect the actual batch report.

About MK-677

Compound context: In clinical trialsAlso known as: Ibutamoren · L-163191 · Nutrobal

MK-677 is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.

What to check before you buy MK-677:

  • Confirm capsule count and milligrams per capsule on the finished product label.
  • Check that the actual report identifies the finished capsule product and matches its batch and strength.
  • Compare bottle price separately from price per capsule and price per milligram. Missing quantities cannot support normalized comparisons.

Research context — not capsule instructions or evidence of equivalent dosing: Nass et al. (Ann Intern Med 2008) ran a 2-year randomised placebo-controlled trial of MK-677 25mg/day in healthy elderly adults; the active arm sustained GH and IGF-1 in the young-adult range, increased fat-free mass by ~1.1kg, but did not improve strength or function and worsened fasting glucose and HbA1c.[4] Murphy et al. (J Clin Endocrinol Metab 1998) characterised the GH pharmacodynamics of MK-677.[5] Lumos Pharma is advancing oral MK-677 (LUM-201) in pediatric growth hormone deficiency (OraGrowtH210 and OraGrowtH212 trials), fragile X syndrome, and SHOX deficiency.[1][6]

Regulatory: Compound-level context, not approval of the capsule listings: Not FDA-approved. Lumos Pharma (LUM-201) in active Phase 2/3 development for pediatric GHD, fragile X syndrome, and SHOX deficiency. FDA warning letters against consumer marketing. Not banned by WADA in-competition but classified as a growth-hormone-releasing factor for anti-doping purposes — banned for athletes.

Read the full mechanism & research breakdown

MK-677: Mechanisms, Half-Life & Research Data

Compound research context for MK-677, not capsule dosing guidance. Studies of other formulations do not establish equivalence to these listings. All citations resolve to the sources list at the bottom of this page.

How it works

Research on the compound and other formulations does not establish the properties or dose of the capsules listed here. MK-677 is a non-peptide small molecule that mimics ghrelin at the GHSR-1a receptor in the anterior pituitary and hypothalamus.[2] Activation of pituitary GHSR-1a directly stimulates somatotroph release of growth hormone and also amplifies hypothalamic GHRH pulses, producing both higher GH-pulse amplitude and an increase in GH-pulse frequency; the downstream effect is a sustained elevation of IGF-1.[5] Because MK-677 acts on the same axis as endogenous ghrelin, it preserves the pulsatile pattern of GH release rather than producing the continuous square-wave elevation seen with exogenous recombinant GH — a pharmacology that the Lumos pediatric program leverages because it more closely mirrors physiological GH secretion. Hypothalamic GHSR-1a agonism also drives appetite (the same hunger-stimulating signal ghrelin produces endogenously), which is the most-reported subjective effect at consumer doses.

Active research areas

  • Pediatric growth hormone deficiency (Lumos LUM-201)
    Lumos is advancing oral LUM-201 (ibutamoren) through OraGrowtH210 and follow-on studies as an oral alternative to daily recombinant GH injections in pediatric idiopathic GH deficiency with sufficient endogenous somatotroph function.[1][6]
  • Fragile X syndrome (Lumos pipeline)
    A Lumos Phase 2 program is testing LUM-201 in fragile X syndrome on the hypothesis that GH/IGF-1 elevation may improve cognitive and behavioural endpoints; this is exploratory and the indication has not been shown to respond to GH-secretagogue therapy in larger trials.[6]
  • Sarcopenia and frailty (healthy-elderly trial, 2008)
    The Nass 2-year trial in healthy older adults showed sustained GH/IGF-1 elevation and a 1.1kg lean-mass gain at 25mg/day but no improvement in strength or function and worsened glucose tolerance, leading to the conclusion that GH-secretagogue monotherapy is not sufficient to translate body-composition changes into functional benefit in this population.[4]
  • Hip-fracture recovery (Phase 2b)
    A multicenter Phase 2b in patients recovering from hip fracture showed safety but did not establish a functional benefit large enough to support a Phase 3 program.[7]
Sources & references (9)

Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.

  1. [1]ClinicalTrials.gov: NCT04614337 — OraGrowtH210 Phase 2 study of LUM-201 (oral ibutamoren) in pediatric growth hormone deficiency. link
  2. [2]Patchett AA et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 1995;92:7001–7005. · PMID: 7624358 link
  3. [3]FDA Warning Letter — Iron Mag Labs, October 2017 — cites MK-677 (ibutamoren) as an unapproved new drug marketed as a dietary supplement. link
  4. [4]Nass R et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008;149:601–611. · PMID: 18981485 link
  5. [5]Murphy MG et al. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. J Bone Miner Res 1999;14:1182–1188. · PMID: 10404020 link
  6. [6]Lumos Pharma. LUM-201 development overview (corporate pipeline page). link
  7. [7]Adunsky A et al. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr 2011;53:183–189. · PMID: 21035876 link
  8. [8]Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev 2018;6:45–53. · PMID: 28433619 link
  9. [9]Community report — r/MK677 and r/Peptides ibutamoren experience threads (subreddits), accessed May 2026. link

What MK-677 Capsules Costs Right Now

WPA currently tracks MK-677 Capsules from 3 distinct vendors. In-stock MK-677 Capsules bottles run from $62.96 to $182.40 — a 2.9x spread for the same compound. Swiss Chems holds the lowest sticker price at $62.96. Normalized to milligrams, MK-677 Capsules costs $0.084/mg to $0.122/mg on this page. The best per-milligram value is the listed 750 mg purchase quantity from Modified Aminos.

MK-677 Capsules is stocked in 3 sizes: 600 mg per package; 750 mg per package; 1500 mg per package. Because bottles of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.

Ranked by true cost per milligram, the MK-677 Capsules listings WPA tracks are: Modified Aminos — 750mg at $62.99 ($0.084/mg); Swiss Chems — 600mg at $62.96 ($0.105/mg), COA purity 98.00%; Paramount Peptides — 1500mg at $182.40 ($0.122/mg).

MK-677 Capsules COA Coverage Across Tracked Vendors

3 of the 3 tracked MK-677 Capsules listings (100%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. A purity value is recorded for 1 listing; purity alone does not establish identity or independent testing. The recorded purity value is 98.00%. The latest COA date recorded in WPA's listing data is 8/26.

To assess a COA, inspect the actual report for the independent lab, test date, and a batch and bottle size matching the MK-677 Capsules offer. WPA's listing fields do not establish that a report was independently verified.

MK-677 Capsules Discount Codes

3 of the 3 tracked MK-677 Capsules listings carry a WPA researcher discount code. The largest live discount is 10% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.

About MK-677

MK-677 is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.

MK-677 is tracked under the Muscle Peptides category on WPA. Compound-level context, not approval of the capsule listings: Not FDA-approved.

How to Read the MK-677 Capsules Comparison

  • Price per milligram — Every MK-677 Capsules listing is normalized to $0.084/mg-style unit pricing, so a small cheap bottle cannot hide a worse real cost than a larger one.
  • COA metadata and purity — 3 MK-677 Capsules listings are marked for COA availability, and 1 has a recorded purity value. These fields do not independently verify a report.
  • Bottles sizes — The MK-677 Capsules comparison includes 600mg, 750mg, and 1500mg listed purchase quantities. Check package composition separately.
  • Stock status — Live in-stock state for each MK-677 Capsules listing, refreshed on a recurring basis.

Reading MK-677 Capsule Listings

Capsule listings are ranked on total MK-677 per bottle — capsule count multiplied by milligrams per capsule — rather than on bottle price, because a cheaper bottle with fewer or weaker capsules routinely costs more per milligram. A capsule COA should test the finished capsule rather than the raw powder, and it should cover the exact capsule strength on sale.

Oral capsule formats differ from injectable vials in route of administration and bioavailability, so a MK-677 protocol written for one format does not transfer to the other. Confirm the vendor's COA covers the capsule product specifically.

Frequently Asked Questions: MK-677 Capsules

How are MK-677 capsule prices compared?

Bottle price, capsule count, and milligrams per capsule are separate listing fields. Total milligrams per bottle equals capsule count × milligrams per capsule; price per milligram divides the bottle price by that total. Price per capsule divides the bottle price by the capsule count. A missing quantity leaves the corresponding normalized price unavailable.

Are MK-677 capsules supplied as powder for reconstitution?

These listings are capsules, not vials for reconstitution. Check the finished capsule label, capsule count, strength, and matching batch report. Vial preparation instructions do not apply to capsule listings.

Can calculator entries establish a MK-677 capsule protocol?

No. WPA calculator entries are compound-wide inputs, not confirmed administration or capsule-specific usage. They do not establish a capsule dose, schedule, bottle duration, or monthly protocol cost. This page compares catalog prices without seeding a capsule monthly planner.

Can MK-677 capsule and injectable doses be converted?

No route-equivalent dose can be inferred from these listings. Absorption depends on the compound and formulation; a generic absorption percentage or multiplier cannot establish capsule dosing. Cited studies of other formulations are research context, not instructions for the capsules offered here.